BUSINESS● LOWSep 22 · Sep 22, 2026, 10:18 AM
FDA Approves Fayuvi. What Does It Mean for Ultragenyx (RARE)’s 2027 Profitability Target?
Yahoo Finance · north america
The FDA has approved Fayuvi, which prompts a question about its impact on Ultragenyx's 2027 profitability target. This development has financial implications for the pharmaceutical company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS38m agoHow the transfer of Movistar customers to Tuenti will be doneClarínBUSINESS47m agoWichita airport receives a million-dollar grant to boost new non-stop flights to the East CoastClarín